Back to Authors

Steinkuller, Paul G.

A5055784736 | I4210147586

Mayo Clinic

Texas Children's Hospital

Citations 1

Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity

JAMA Ophthalmology | November 7, 2019 | Volume: 138 | Issue: 1 | Pages: 14

10.1001/jamaophthalmol.2019.4488 | PMID 31697304